16.29
0.06%
-0.01
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
15.77%
4,457.00
|
3,850.00 | 3,878.00 | 3,661.00 | 3,884.00 |
Cost Of Revenue |
2.10%
2,041.00
|
1,999.00 | 2,082.00 | 2,079.00 | 2,113.00 |
Gross Profit |
30.47%
2,415.00
|
1,851.00 | 1,796.00 | 1,582.00 | 1,770.00 |
Operating Expenses |
13.17%
1,693.00
|
1,496.00 | 2,442.00 | 1,580.00 | 2,625.00 |
Benefits Costs and Expenses |
5.54%
3,984.00
|
3,775.00 | 4,792.00 | 3,919.00 | 4,985.00 |
Costs And Expenses |
5.54%
3,984.00
|
3,775.00 | 4,792.00 | 3,919.00 | 4,985.00 |
Depreciation and Amortization |
6.01%
266.00
|
283.00 | 300.00 | 304.00 | 306.00 |
Operating Income/Loss |
109.88%
722.00
|
344.00 | -654.00 | -13.00 | -855.00 |
Nonoperating Income/Loss |
11.07%
-249.00
|
-280.00 | -268.00 | -260.00 | -245.00 |
Income/Loss Before Equity Method Investments |
639.06%
473.00
|
64.00 | -923.00 | -272.00 | -1,101.00 |
Income/Loss From Continuing Operations Before Tax |
639.06%
473.00
|
64.00 | -923.00 | -272.00 | -1,101.00 |
Income Tax Expense/Benefit |
441.67%
41.00
|
-12.00 | -16.00 | -19.00 | 154.00 |
Income/Loss From Continuing Operations After Tax |
468.42%
432.00
|
76.00 | -907.00 | -253.00 | -1,255.00 |
Net Income/Loss
|
455.13%
433.00
|
78.00 | -905.00 | -253.00 | -1,254.00 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
50.00%
4.00
|
8.00 | -35.00 | -33.00 | -32.00 |
Basic Average Shares |
100.00%
-
|
1,121.00 | 1,120.00 | 1,115.00 | 1.00 |
Diluted Average Shares |
100.00%
-
|
1,135.00 | 1,120.00 | 1,115.00 | 1.00 |
Basic Earnings Per Share |
533.33%
0.38
|
0.06 | -0.78 | -0.20 | -1.10 |
Diluted Earnings Per Share |
533.33%
0.38
|
0.06 | -0.78 | -0.20 | -1.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):